Expertise in
10
conditions

Kyriakos Martakis

Koeln, NW, DE 
Expertise in
10
conditions
Koeln, NW, DE 

Overview

Kyriakos Martakis practices practicing medicine in Koeln, Germany.

Mr. Martakis is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Niemann-Pick Disease, Tay-Sachs Disease, Gangliosidosis, and Non-Langerhans-Cell Histiocytosis.

He is actively involved in clinical research, co-authoring 57 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Koeln, NW, Germany
Other Locations
Giessen, HE, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Effects of N-Acetyl-L-Leucine on GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease): A Multinational, Multicenter, Open-label, Rater-blinded Phase II Study
Effects of N-Acetyl-L-Leucine on GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease): A Multinational, Multicenter, Open-label, Rater-blinded Phase II Study
Enrollment Status: Completed
Publish Date: March 12, 2024
Intervention Type: Drug
Study Drug: IB1001
Study Phase: Phase 2
Effects of N-Acetyl-L-Leucine on Niemann Pick Type C Disease: A Multinational, Multicenter, Open-label, Rater-blinded Phase II Study.
Effects of N-Acetyl-L-Leucine on Niemann Pick Type C Disease: A Multinational, Multicenter, Open-label, Rater-blinded Phase II Study.
Enrollment Status: Completed
Publish Date: November 28, 2023
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

57 Total Publications

Safety and feasibility of oral zinc for patients with GNAO1-related disorders (ZINCGNAO1): an open-label, single-arm, single-centre, pilot trial in Germany.
Safety and feasibility of oral zinc for patients with GNAO1-related disorders (ZINCGNAO1): an open-label, single-arm, single-centre, pilot trial in Germany.
Journal: EClinicalMedicine
Published: May 26, 2026

Frequently Asked Questions about Kyriakos Martakis

Is Kyriakos Martakis a top-rated expert for Niemann-Pick Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Kyriakos Martakis is classified as an Distinguished expert for Niemann-Pick Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Kyriakos Martakis participate in research or clinical trials?

Yes. Kyriakos Martakis has published 57 articles and abstracts on conditions like Niemann-Pick Disease. You can view a list of Kyriakos Martakis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Martakis's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile